TIME AND SPACE COMPLEXITY ANALYSIS OF RSA AND ELGAMAL CRYPTOGRAPHIC ALGORITHMS ON MIXED DATA

The complexity study of algorithms, especially computationally intensive ones is of great significance in the field of complexity. Cryptographic algorithms are considered to be computationally intensive because they utilize a substantial number of computational resources, such as CPU memory and processing time. Cryptographic algorithms provide a solution to the security of data transmission whereby ensuring integrity, confidentiality and authentication of any form of data. However, there are still challenges of which cryptographic algorithms are suitable in terms of computation speed and memory usage. Whereas, a good number of research efforts have been put into experimenting on the complexities of the cryptographic algorithm on text, image and audio data, little has been done on video data. In this study, the time and space complexity of RSA and ElGamal cryptographic algorithms on mixed data was carried out. RSA and ElGamal cryptographic algorithms was implemented using C-sharp (C#) programming language to encrypt and decrypt text, image, audio and video dataset. In achieving the objectives of the study, both the implemented algorithms (RSA and ElGamal) are depicted using pseudocodes and flowcharts, while some of the datasets used were sourced from various online repositories. The time complexities of each dataset was obtained using the CPU internal clock while the space usage for each operations on each of the dataset was obtained using the computer internal memory. Tables and graphs was used to carry out the comparative analysis of both algorithms. The time and space complexity of RSA and ElGamal algorithms were experimented on text, image, audio and video dataset. The experimental results revealed that RSA outperformed ElGamal in terms of computational time during encryption of all categories of data. ElGamal outperformed RSA in terms of computational time during decryption of all categories of data. ElGamal algorithm outperformed RSA in terms of memory usage during encryption of all categories of data while both algorithms used relatively the same amount of space during decryption of all categories of data used. Based on the comparative analysis of the time and space complexity on both RSA and ElGamal algorithms, it was discovered that RSA is a better algorithm when it comes to time complexity, that is, RSA can be said to be a time-efficient algorithm. ElGamal algorithm performed better than RSA in the memory usage aspect, therefore the ElGamal algorithm is said to be a memory-efficient algorithm. Therefore, this study hereby recommend that other measurement metrics may be used to compare both algorithms in future works

Computational Complexity of Modified Blowfish Cryptographic Algorithm on Video Data

Background: The technological revolution has allowed users to exchange data and information in various fields, and this is one of the most prevalent uses of computer technologies. However, in a world where third parties are capable of collecting, stealing, and destroying information without authorization, cryptography remains the primary tool that assists users in keeping their information secure using various techniques. Blowfish is an encryption process that is modest, protected, and proficient, with the size of the message and the key size affecting its performance. Aim: the goal of this study is to design a modified Blowfish algorithm by changing the structure of the F function to encrypt and decrypt video data. After which, the performance of the normal and modified Blowfish algorithm will be obtained in terms of time complexity and the avalanche effect. Methods: To compare the encryption time and security, the modified Blowfish algorithm will use only two S-boxes in the F function instead of the four used in Blowfish. Encryption and decryption times were calculated to compare Blowfish to the modified Blowfish algorithm, with the findings indicating that the modified Blowfish algorithm performs better. Results: The Avalanche Effect results reveal that normal Blowfish has a higher security level for all categories of video file size than the modified Blowfish algorithm, with 50.7176% for normal Blowfish and 43.3398% for the modified Blowfish algorithm of 187 kb; hence, it is preferable to secure data and programs that demand a high level of security with Blowfish. Conclusions: From the experimental results, the modified Blowfish algorithm performs faster than normal Blowfish in terms of time complexity with an average execution time of 250.0 ms for normal Blowfish and 248.4 ms for the modified Blowfish algorithm. Therefore, it can be concluded that the modified Blowfish algorithm using the F-structure is time-efficient while normal Blowfish is better in terms of security.publishedVersio

Smart transit payment for university campus transportation using RFID card system

In the transportation business, we aim to be cost-efficient and effective in our customer service but with the traditional transit payment system, it is not so. Lately, transit companies all over the world are moving towards superior client service, nimbleness, receptiveness to necessities that diverge at a time scale that was absurd even two decades ago. The aim of this study was to create an electronic transit payment system that will allow for full pliability and solutions functionality that Covenant Universities and Nigerian transit companies should adopt to become more effective and efficient. We achieved this with the use of radio frequency identification (RFID) smart cards and card readers aiding a computer program that was programmed using C#. In addition, the program was simple and not expensive to implement in order to eliminate the mismanagement of ticket funds, loiter paper in bus stations, and so on. Together all this became our payment system

Semantics-based clustering approach for similar research area detection

The manual process of searching out individuals in an already existing research field is cumbersome and time-consuming. Prominent and rookie researchers alike are predisposed to seek existing research publications in a research field of interest before coming up with a thesis. From extant literature, automated similar research area detection systems have been developed to solve this problem. However, most of them use keyword-matching techniques, which do not sufficiently capture the implicit semantics of keywords thereby leaving out some research articles. In this study, we propose the use of Ontology-based pre-processing, Latent Semantic Indexing and K-Means Clustering to develop a prototype similar research area detection system, that can be used to determine similar research domain publications. Our proposed system solves the challenge of high dimensionality and data sparsity faced by the traditional document clustering technique. Our system is evaluated with randomly selected publications from faculties in Nigerian universities and results show that the integration of ontologies in preprocessing provides more accurate clustering results

Crypto-Stegno based model for securing medical information on IOMT platform

The integration of the Internet of Things in medical systems referred to as the Internet of Medical Things (IoMT), which supports medical events for instance real-time diagnosis, remote monitoring of patients, real-time drug prescriptions, among others. This aids the quality of services provided by the health workers thereby improve patients’ satisfaction. However, the integrity and confidentiality of medical information on the IoMT platform remain one of the contentions that causes problems in medical services. Another serious concern with achieving protection for medical records is information confidentiality for patient’s records over the IoMT environment. Therefore, this paper proposed a Crypto-Stegno model to secure medical information on the IoMT environment. The paper validates the system on healthcare information datasets and revealed extraordinary results in respect to the quality of perceptibility, extreme opposition to data loss, extreme embedding capability and security, which made the proposed system an authentic strategy for resourceful and efficient medical information on IoTM platform

Development of an Improved Convolutional Neural Network for an Automated Face Based University Attendance System

Because of the flaws of the present university attendance system, which has always been time intensive, not accurate, and a hard process to follow. It, therefore, becomes imperative to eradicate or minimize the deficiencies identified in the archaic method. The identification of human face systems has evolved into a significant element in autonomous attendance-taking systems due to their ease of adoption and dependable and polite engagement. Face recognition technology has drastically altered the field of Convolution Neural Networks (CNN) however it has challenges of high computing costs for analyzing information and determining the best specifications (design) for each problem. Thus, this study aims to enhance CNN’s performance using Genetic Algorithm (GA) for an automated face-based University attendance system. The improved face recognition accuracy with CNN-GA got 96.49% while the face recognition accuracy with CNN got 92.54%

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Background: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. Methods: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. Findings: Global DALYs increased from 2·63 billion (95% UI 2·44–2·85) in 2010 to 2·88 billion (2·64–3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7–17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8–6·3) in 2020 and 7·2% (4·7–10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0–234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7–198·3]), neonatal disorders (186·3 million [162·3–214·9]), and stroke (160·4 million [148·0–171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54–1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5–9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0–19·8]), depressive disorders (16·4% [11·9–21·3]), and diabetes (14·0% [10·0–17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7–27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6–63·6) in 2010 to 62·2 years (59·4–64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6–2·9) between 2019 and 2021. Interpretation: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. Funding: Bill & Melinda Gates Foundation

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation